Skip navigation
SuUB logo
DSpace logo

  • Home
  • Institutions
    • University of Bremen
    • City University of Applied Sciences
    • Bremerhaven University of Applied Sciences
  • Sign on to:
    • My Media
    • Receive email
      updates
    • Edit Account details

Citation link: http://nbn-resolving.de/urn:nbn:de:gbv:46-00105165-15
00105165-1.pdf
OpenAccess
 
copyright

Eine extra-welfaristische Evaluation der Arzneimittelregulierung


File Description SizeFormat
00105165-1.pdf20.45 MBAdobe PDFView/Open
Other Titles: Extra-welfaristic Evaluation of Pharmaceutical Regulation
Authors: Salomon, Tina  
Supervisor: Rothgang, Heinz
1. Expert: Rothgang, Heinz
2. Expert: Gerhardus, Ansgar 
Abstract: 
Since 1961 access to market for innovative pharmaceuticals was increasingly regulated. The first step was a simple registration procedure, followed by federal licensing in 1978. Since 1989 the licensing was complemented by price control in form of a maximum allowable cost scheme ("Festbetragsregelung"). Since 2004 the additional benefit of new medicines is determined as a mean to guarantee acceptable "value for money" for the statutory health insurance. This thesis evaluates this aggregate of regulatory mechanisms particurlarly with regard to the quality of the supply of new medicines.
Keywords: Gesundheit, Arzneimittel, Wohlfahrtsökonomik, Extra-Welfarismus
Issue Date: 13-Apr-2016
Type: Dissertation
URN: urn:nbn:de:gbv:46-00105165-15
Institution: Universität Bremen 
Faculty: FB11 Human- und Gesundheitswissenschaften 
Appears in Collections:Dissertationen

  

Page view(s)

37
checked on Jan 25, 2021

Download(s)

29
checked on Jan 25, 2021

Google ScholarTM

Check


Items in Media are protected by copyright, with all rights reserved, unless otherwise indicated.

Legal notice -Feedback -Data privacy
Media - Extension maintained and optimized by Logo 4SCIENCE